Top-News
Professionelle Dienstleistungen USA

Exact Sciences News

Aktie
WKN:  590273 ISIN:  US30063P1057 US-Symbol:  EXAS
47,895 €
-2,155 €
-4,31%
24.05.24 18:20:42
Handeln Depot/Watchlist
Aktienanzahl *
180,66 Mio.
Marktkapitalisierung *
8,30 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 16.09.2023

Exact Sciences News

07.01.24 - PR Newswire
Exact Sciences Announces Preliminary Fourth Quarter 2023 Results
Exact Sciences Announces Preliminary Fourth Quarter 2023 Results PR Newswire
02.01.24 - PR Newswire
Exact Sciences to participate in J.P. Morgan Healthcare Conference
Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire
07.12.23 - PR Newswire
Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings
Exact Sciences Awards Grants to 23 Organizations Focused on Increasing Colorectal Cancer Screenings PR Newswire
01.12.23 - PR Newswire
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients PR Newswire
30.11.23 - PR Newswire
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients
Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients PR Newswire
17.11.23 - PR Newswire
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy PR Newswire
01.11.23 - PR Newswire
Exact Sciences Announces Third-Quarter 2023 Results
Exact Sciences Announces Third-​Quarter 2023 Results PR Newswire
01.11.23 - PR Newswire
Exact Sciences to participate in November investor conferences
Exact Sciences to participate in November investor conferences PR Newswire
22.10.23 - PR Newswire
Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection
Next-​Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for ...
20.10.23 - PR Newswire
Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress
Exact Sciences Advances Early Cancer Detection and Precision Oncology Programs with Data Presentations at ESMO 2023 Annual Congress PR Newswire
09.10.23 - PR Newswire
Exact Sciences schedules third quarter 2023 earnings call
Exact Sciences schedules third quarter 2023 earnings call PR Newswire
09.10.23 - PR Newswire
Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023
Exact Sciences to Present Late-​Breaking Data from Pivotal BLUE-C Study on Next-​Generation Cologuard at ACG 2023 PR Newswire
01.09.23 - PR Newswire
Exact Sciences to participate in September investor conference
Exact Sciences to participate in September investor conference PR Newswire
30.08.23 - PR Newswire
Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials
Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials PR Newswire
21.08.23 - PR Newswire
Not a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-Olds Are Avoiding Colorectal Cancer Screenings
Not a Wall, But an Obstacle Course: New Findings Reveal Why 45-Year-​Olds Are Avoiding Colorectal Cancer Screenings PR Newswire
01.08.23 - PR Newswire
Exact Sciences Announces Second-Quarter 2023 Results
Exact Sciences Announces Second-​Quarter 2023 Results PR Newswire
10.07.23 - PR Newswire
Exact Sciences schedules second quarter 2023 earnings call
Exact Sciences schedules second quarter 2023 earnings call PR Newswire
23.06.23 - wallstreet:online Zentralredaktion
Krebsfrüherkennung : Biotech-Kursrakete Exact Sciences: +90 Prozent in diesem Jahr! Geht da noch was?
Die Aktie des US-​Biotech-Unternehmens Exact Sciences ist in diesem Jahr um fast 90 Prozent gestiegen. Doch ein Fondsmanager ist überzeugt: Die Rally ist noch nicht vorbei! ...
21.06.23 - PR Newswire
Thinking about trading options or stock in Tesla, Microsoft, Exact Sciences, Coinbase Global, or Logitech International?
Thinking about trading options or stock in Tesla, Microsoft, Exact Sciences, Coinbase Global, or Logitech International? PR Newswire
21.06.23 - PR Newswire
Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations
Exact Sciences Advances Innovative Cancer Technologies and Approaches Through Visionary Collaborations PR Newswire

Newssuche

Videos

23.05.24 +3,63%
Technical Trading: Sojabohnen im saisonalen Trend
Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »